Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
AGN [NYSE]
Allergan Inc.
IndexS&P 500 P/E49.56 EPS (ttm)4.29 Insider Own9.90% Shs Outstand297.90M Perf Week2.00%
Market Cap63.34B Forward P/E24.89 EPS next Y8.54 Insider Trans-0.01% Shs Float297.35M Perf Month0.02%
Income1.30B PEG2.42 EPS next Q1.83 Inst Own92.90% Short Float1.03% Perf Quarter28.03%
Sales7.01B P/S9.03 EPS this Y17.60% Inst Trans-0.70% Short Ratio0.97 Perf Half Y29.08%
Book/sh23.95 P/B8.88 EPS next Y35.67% ROA11.80% Target Price218.44 Perf Year105.18%
Cash/sh14.05 P/C15.13 EPS next 5Y20.46% ROE19.30% 52W Range100.33 - 214.66 Perf YTD91.66%
Dividend0.20 P/FCF45.29 EPS past 5Y17.90% ROI15.70% 52W High-0.95% Beta0.76
Dividend %0.09% Quick Ratio3.70 Sales past 5Y7.40% Gross Margin88.10% 52W Low111.92% ATR3.41
Employees11500 Current Ratio3.90 Sales Q/Q16.60% Oper. Margin30.80% RSI (14)62.77 Volatility1.53% 1.23%
OptionableYes Debt/Eq0.30 EPS Q/Q-6.40% Profit Margin18.50% Rel Volume1.06 Prev Close212.18
ShortableYes LT Debt/Eq0.29 EarningsOct 27 BMO Payout4.60% Avg Volume3.16M Price212.63
Recom2.20 SMA200.74% SMA507.06% SMA20026.49% Volume3,357,565 Change0.21%
Dec-17-14Downgrade UBS Buy → Neutral $206 → $219
Dec-15-14Downgrade Stifel Buy → Hold
Oct-09-14Initiated Deutsche Bank Buy $215
Oct-01-14Upgrade Stifel Hold → Buy $200
Jul-22-14Upgrade UBS Neutral → Buy $180 → $200
Apr-28-14Downgrade Stifel Buy → Hold
Apr-22-14Downgrade Argus Buy → Hold
Mar-07-14Reiterated Barclays Equal Weight $95 → $130
Feb-07-14Reiterated Argus Buy $110 → $130
Jan-08-14Reiterated Argus Buy $110 → $125
Jan-07-14Initiated RBC Capital Mkts Outperform $131
Dec-20-13Reiterated UBS Buy $100 → $116
Dec-20-13Reiterated BMO Capital Markets Outperform $112 → $117
Oct-31-13Reiterated Argus Buy $118 → $110
Jun-25-13Reiterated Canaccord Genuity Hold $111 → $98
Jun-24-13Downgrade Deutsche Bank Buy → Hold
May-02-13Reiterated RBC Capital Mkts Outperform $123 → $119
Feb-06-13Reiterated Stifel Nicolaus Buy $110 → $118
Feb-06-13Reiterated Canaccord Genuity Hold $102 → $111
Jan-22-13Reiterated Canaccord Genuity Hold $101 → $102
Dec-18-14 07:10PM  Ackman Accused of Insider Trading in Allergan Shareholder Suit at Bloomberg
05:48PM  AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 -- AGN GlobeNewswire
05:39PM  Farallon Capital starts new position in Time Warner Inc. Market Realist
04:34PM  Lawsuit accuses Ackman, Valeant of insider trading in Allergan stock at Los Angeles Times
03:59PM  EQUITY ALERT: The Rosen Law Firm Announces the Filing of Securities Class Action on Behalf of Sellers of Allergan Inc. Stock From February 25, 2014 to April 21, 2014 Seeking to Recover Losses -- AGN GlobeNewswire
01:43PM  Elliott sells out its position in Allergan Market Realist
Dec-17-14 01:47PM  COTCHETT, PITRE & McCARTHY, LLP Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014 Business Wire
11:15AM  Deadline in Lawsuit for Certain Sellers of Allergan, Inc. (AGN) Shares Announced by Shareholders Foundation GlobeNewswire
11:06AM  Allergan downgraded by UBS Briefing.com
09:30AM  BOTTINI & BOTTINI, INC. Files Class Action Lawsuit On Behalf Of Persons Who Sold Allergan Stock Between February 25, 2014 And April 21, 2014 PR Newswire
Dec-16-14 10:12PM  Few Allergan execs to keep top jobs in Actavis takeover at Los Angeles Times
06:11PM  Great Stocks: Valeant Pharmaceuticals Near Buy Point at Investor's Business Daily
10:28AM  Actavis Unveils Management Changes at The Wall Street Journal
09:49AM  Activis to Replace Most Allergan Executives After Deal at Bloomberg
Dec-10-14 04:20PM  Roche (RHHBY) Presents Positive Data on Haemophilia Drug Zacks
08:16AM  The Zacks Analyst Blog Highlights: Novartis, Amgen, Incyte and Allergan Zacks
Dec-09-14 06:15PM  Companies begging for activist to strike: Cramer CNBC
01:38PM  Where Could ValueAct Capital's New $1.5 Billion Go? Benzinga
08:41AM  Valeant puts dealmaking on hold to focus on the bottom line at Fortune
Dec-07-14 04:27PM  Reports: Merck in talks to buy Cubist at USA TODAY
Dec-06-14 04:06AM  My 2014 Healthcare Top 10 List at Forbes
Dec-05-14 04:49PM  Sanofi Buys Merck's Manufacturing Facility in Puerto Rico Zacks
12:48PM  Activist Investors Torn on Private Equity Partnerships at TheStreet
09:17AM  Goldman's Parker Calls Allergan Pursuit a 'One-time Opportunity' at TheStreet
Dec-03-14 06:53PM  Jim Cramer's 'Mad Money' Recap: Cyclical Stocks Are Fund Manager Picks Now at TheStreet
03:45PM  AstraZeneca's (AZN) Iressa Accepted for Review in the U.S. Zacks
Dec-02-14 06:19PM  U.S. Stock Mutual Funds Led Advance In November at Investor's Business Daily
05:45PM  Actavis Launches Generic of Shire's ADHD Drug Intuniv Zacks
Dec-01-14 02:59PM  ALLERGAN INC Files SEC form 8-K, Other Events EDGAR Online
Nov-26-14 04:30PM  AstraZeneca/Amgen's Brodalumab Excels in Psoriasis Study Zacks
12:30PM  AstraZeneca's (AZN) Respiratory Drug Approved in the EU Zacks
08:59AM  Ackman's Pershing Square still holds 26.6 million Allergan shares Reuters
Nov-25-14 06:35PM  5 Ways CEOs Handle Activist Investors at The Wall Street Journal
08:00AM  JANA Partners adds a new position in Valeant Pharmaceuticals Market Realist
Nov-24-14 05:16PM  [$$] Salix Plans to Boost Size of Board at The Wall Street Journal
04:18PM  Taking Stock: McCracken on Smith & Nephew Deal Coming Back at Bloomberg
04:00PM  Viking Global Investors increases stakes in Allergan Market Realist
02:46PM  Investors Who Sold Allergan (AGN) Shares Between April 1, 2014 and April 21, 2014 May Contact Gardy & Notis, LLP Law Firm For Further Information PR Newswire
12:48PM  Actavis Plans Job Cuts, China Expansion for Allergan at Bloomberg
07:22AM  Cramer: When Can a Solid CEO Catch a Break? TheStreet
Nov-21-14 11:15PM  Review at Barrons.com
10:54PM  [$$] Charting the Market at Barrons.com
06:27PM  ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Business Wire
04:00PM  Amgen and AbbVie Strengthen Manufacturing Facilities in Asia Zacks
03:49PM  Podcast: Do Allergan, Actavis, and Ackman Hint at a Market Top? at The Wall Street Journal
08:26AM  Allergan deal sits well on Actavis chief's 'Monopoly board' at Financial Times
04:11AM  After losing out over Allergan, Valeant announces $2 billion buyback at Fortune
Nov-20-14 06:28PM  Ackman-Valeant Alliance Proved Unwieldy at The Wall Street Journal
12:13PM  [$$] Valeant Sets $2 Billion Buyback Plan at The Wall Street Journal
Nov-19-14 06:48PM  For Allergan Suitors, Unorthodox Alliance Proved Unwieldy at The Wall Street Journal
06:14PM  Valeant Rises After Allergan Snub; Zeltiq In Buy Area at Investor's Business Daily
03:20PM  AstraZeneca Targets More than $45B in Revenues in 2023 Zacks
01:57PM  AGN SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc Business Wire
10:26AM  US stocks retreat from records before Fed release at CNBC
09:03AM  That's Funny, you Look Just Like Allergan CEO David Pyott at The Wall Street Journal
08:37AM  Allergan's Price Tag Gets Even Richer at The Wall Street Journal
07:58AM  The Zacks Analyst Blog Highlights: Actavis, Allergan, iShares U.S. Pharmaceuticals ETF, Market Vectors Pharmaceutical ETF and SPDR S&P Pharmaceuticals ETF Zacks
07:42AM  Can the Uptrend Continue for Allergan (AGN)? Zacks
Nov-18-14 07:32PM  Cramer Remix: Warning to the skeptics at CNBC
06:26PM  Stocks rally: Dow, S&P 500 set closing highs at USA TODAY
06:19PM  [$$] Ackman Drops Push for Allergan Meeting at The Wall Street Journal
05:31PM  ALLERGAN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E EDGAR Online
05:04PM  Vipshop, Jack in the Box Rise In After-Hours Trading at Investor's Business Daily
05:02PM  Dow, S&P 500 Add To Gains Following Encouraging International News Benzinga
04:17PM  Stocks Hit New Milestones; BitAuto Rebounds at Investor's Business Daily
03:48PM  Lifshitz & Miller Law Firm Announces Investigation of Allergan, Inc., Baker Hughes Incorporated, ChyronHego Corp., Horizon Lines, Inc., Susquehanna Bancshares, Inc., Swift Energy Company and Valley Financial Corporation PR Newswire
03:15PM  Zoetis 2015 Guidance Misses As Buyout Theories Abound at Investor's Business Daily
02:58PM  [$$] Actavis-Allergan Deal Friendly to Shareholders at Barrons.com
02:38PM  Stock Movers: Why 4 Big Drug Stocks Are Rising Today at Investor's Business Daily
01:53PM  Deals Heat Up for Lawyers Like Its 1998 Bloomberg
01:38PM  Ackman supports Allergan's $66 billion sale to Actavis Reuters
01:33PM  Stocks Hold Near Fresh Milestones; Actavis Hits New High at Investor's Business Daily
01:10PM  Ackman Pledges Support For Actavis Bid On Allergan Benzinga
12:56PM  Midday movers: Allergan, Apple, Fluor & more at CNBC
12:30PM  Actavis shares outpace buyout targets gains at MarketWatch
12:20PM  Actavis Strikes $66 Billion Deal for Botox Maker Allergan Zacks
12:08PM  Ackman withdraws special Allergan meeting CNBC
11:47AM  Jim Cramer: Which Stocks Stand Out as Winners? Here's My List at TheStreet
11:45AM  Ackman says supports Allergan's $66 billion sale to Actavis: CNBC Reuters
11:43AM  Ackman says supports Allergan's $66 billion sale to Actavis -CNBC Reuters
11:29AM  Dealpolitik: Praise for Allergan Directors, Not Pershing Square at The Wall Street Journal
11:18AM  AGN INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc -- AGN PR Newswire
10:33AM  Stocks Most Loved By Hedge Funds at Barrons.com
10:30AM  Japan: 'Abenomics ' delivering? CNBC
10:27AM  Ackman to CNBC: Support Actavis-Allergan deal CNBC
09:22AM  Cramer's Mad Dash: Zoetis' buyback CNBC
09:03AM  [$$] Actavis Outlines Allergan Breakup Fee at The Wall Street Journal
09:01AM  Global M&A boom tops $3 trillion this year at Fortune
08:51AM  Cramer's stocks to watch: AAPL, AGN & HD CNBC
07:45AM  Pharma ETFs in Focus on Allergan Takeover Deal Zacks
07:23AM  #PreMarket Primer: Tuesday, November 18: Abe To Delay Sales Tax Increase In Japan Benzinga
06:26AM  Zacks Investment Ideas feature highlights: Allergan, Actavis, Sketchers and Zeltiq Aesthetics Zacks
06:08AM  Actavis' dealmaking builds drug powerhouse at Financial Times
01:09AM  PRESS DIGEST - Wall Street Journal - Nov 18 Reuters
12:40AM  Actavis Agrees to Buy Botox Maker Allergan at The Wall Street Journal
12:39AM  Jack Lew, Irish Hero at The Wall Street Journal
Nov-17-14 11:30PM  Allergan sale to Actavis thwarts takeover attempt by Valeant at Los Angeles Times +5.31%
10:26PM  Mergers and acquisitions stay on torrid pace at USA TODAY
08:39PM  Actavis to buy Botox maker Allergan for $66B at USA TODAY
08:34PM  PRESS DIGEST- British Business - Nov 18 Reuters
Allergan, Inc. operates as a multi-specialty health care company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and physician-dispensed skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company also holds LiRIS Program, which is in Phase II trials for the treatment of interstitial cystitis/bladder pain syndrome. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. The company focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, urologists, urogynecologists, and general practitioners. It has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sherman Scott DExecutive Vice President, HRApr 22Option Exercise75.5810,000755,80018,223Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 22Sale163.0010,0001,630,0008,223Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 21Option Exercise73.044,500328,68012,723Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 21Sale139.854,500629,3258,223Apr 23 07:25 PM
INGRAM DOUGLAS SPresidentFeb 21Sale125.701961,044Feb 25 05:49 PM
LAVIGNE LOUIS J JRDirectorFeb 21Sale125.795,400679,2440Feb 24 07:59 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Option Exercise40.1638,9001,562,22455,491Feb 21 04:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Option Exercise58.5523,0001,346,65029,401Feb 21 04:56 PM
HUDSON DAWN EDirectorFeb 19Sale126.354,200530,68311,600Feb 21 05:14 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Sale126.3938,9004,916,49316,591Feb 21 04:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Sale126.6623,0002,913,1116,401Feb 21 04:56 PM
Sherman Scott DExecutive Vice President, HRFeb 18Option Exercise75.585,000377,90013,220Feb 19 02:44 PM
Sherman Scott DExecutive Vice President, HRFeb 18Sale125.745,000628,7008,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Option Exercise55.9884,0004,701,90085,058Feb 19 02:41 PM
Sherman Scott DExecutive Vice President, HRFeb 14Sale124.761708,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Sale124.4084,00010,449,4321,058Feb 19 02:41 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Option Exercise36.15252,0009,109,800417,000Feb 13 05:49 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Option Exercise65.9223,8751,573,76930,754Feb 13 05:54 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Sale123.12252,00031,025,560165,000Feb 13 05:49 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Sale123.5223,8752,949,0416,879Feb 13 05:54 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Option Exercise55.9817,000951,57523,401Feb 13 05:56 PM
LAVIGNE LOUIS J JRDirectorFeb 11Option Exercise55.2054,6003,014,01924,123Feb 13 05:59 PM
LAVIGNE LOUIS J JRDirectorFeb 11Sale122.3954,6006,682,69612,723Feb 13 05:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Sale121.8217,0002,070,9576,401Feb 13 05:56 PM
Sherman Scott DExecutive Vice President, HRFeb 10Option Exercise75.585,000377,90013,325Feb 11 08:41 PM
Sherman Scott DExecutive Vice President, HRFeb 10Sale120.005,000600,0008,325Feb 11 08:41 PM
Sherman Scott DExecutive Vice President, HRFeb 07Option Exercise73.044,500328,68012,825Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Option Exercise64.47105,5006,801,585122,371Feb 11 08:37 PM
Sherman Scott DExecutive Vice President, HRFeb 07Sale118.554,500533,4848,325Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Sale117.74105,50012,421,04316,871Feb 11 08:37 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Option Exercise55.9842,0002,350,95059,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Sale117.8042,0004,947,60017,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Option Exercise55.9842,0002,350,95059,327Jan 10 06:37 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Sale113.8042,0004,779,60017,327Jan 10 06:37 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Option Exercise53.7152,5002,819,77545,547Dec 30 05:18 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Sale110.0552,5005,777,5508,047Dec 30 05:18 PM